Dr. Nicholas J. Vogelzang —
Mesothelioma Specialist
Dr. Vogelzang has dedicated his professional life to cancer patients and to cancer research. Beginning with his college research project at Argonne National laboratory near Chicago through a 24 year career at the University of Chicago in cancer care, education and research, to his current position as a senior scientific leader of US Oncology Research, he remains dedicated to curing cancer, one patient at a time. His resume reflects this lifelong dedication to cancer medicine.
Trending News about Dr. Vogelzang
- Lack of Awareness of Late Drug Effects in Cancer Survivors - Medscape May 17, 2012
- Many primary care docs don't know long-term effects of chemo - KTVN May 17, 2012
- Medicamento de J&J, prometedor en cáncer de próstata de alto riesgo - Publico.es May 17, 2012
- Many Primary Care Docs Don't Know Long-Term Effects of Chemo: Survey - MSN Health & Fitness May 17, 2012
- Advanced Prostate Cancer Drug May Help at Earlier Stage - U.S. News & World Report May 17, 2012
- Medical tourism pitch falls flat - Las Vegas Review - Journal May 17, 2012
- Chemo Before Surgery Clears Prostate Cancer - MedPage Today May 16, 2012
- External Beam Radiotherapy: More Toxic, More Expensive - Clinical Oncology News April 24, 2012
View a selection of our videos Or click here to view all our videos
-
Current Mesothelioma Treatment
-
Mesothelioma Symptoms and Risk Factors
-
Origins of Mesothelioma Treatment